P2-306: Activation of both LXRα and LXRβ is required for TO901317-mediated lowering of Aβ42: implications for the development of Alzheimer's therapeutics

Autor: Riddell, D.R., Li, Z., Zhou, H., Aschmies, S., Kouranova, E., Ring, R., Warwick, H.W., Gustafsson, J.A., Steffensen, K.R., Pangalos, M.N., Jacobsen, S.J., Reinhart, P.H.
Zdroj: In Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2008 4(4) Supplement:T462-T462
Databáze: ScienceDirect